跳至主要内容
临床试验/NCT00830726
NCT00830726Unknown不适用

Water-and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung Disease, Evaluated by the Excretion of Aquaporin-2 and Epithelial Sodium Channels in the Urine

Kolding Sygehus1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2009年2月最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
150
试验地点
1
主要终点
Differences in excretion of Aquaporin-2 in urine

研究概览

简要总结

The purpose of the study is to determine whether the excretion of renal water- and salt-channels in the urine reflects the handling of water and salt in the kidneys, and whether the excretion can be used to monitor and/or predict the effects of treatment of certain heart or lung diseases.

详细描述

The purpose of the study is to determine whether the excretion of renal water- and salt-channels (Aquaporin-2 and Epithelial Sodium Channels) in the urine accurately reflects the handling of water and salt in the distal tubules af the kidneys, and whether quantification of these channels in the urine is useful to monitor and/or predict the effects of pharmacologic or surgical treatment of Heart Failure and heart failure-related diseases (Aortic stenosis, acute and chronic ischemic heart disease or pulmonary hypertension)

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic heart failure
  • Severe valvular aortic stenosis
  • Acute Coronary Syndrome
  • Medically refractory chronic angina pectoris or pulmonary hypertension with preserved left ventricular function

排除标准

  • Pregnancy
  • Drug abuse
  • Malignant disease
  • Significant disease of other organs including endocrine diseases

研究组 & 干预措施

2

Patients with symptomatic heart failure and EF < 40%

干预措施: Pharmacologic and mechanical heart failure treatment (Drug)

3

Patients with symptomatic aortic valve stenosis

干预措施: Aortic valve replacement (Procedure)

4

Patients with Acute Coronary syndromes prior to surgical intervention

干预措施: Revascularisation in Acute Coronary Syndrome (Procedure)

5

Patients with refractory stable angina requiring surgical intervention.

干预措施: Revascularisation in chronic stable angina pectoris (Procedure)

结局指标

主要结局

Differences in excretion of Aquaporin-2 in urine

时间窗: 6 months

次要结局

  • Differences in excretion of Epithelial Sodium Channels in urine(6 months)

研究者

发起方
Kolding Sygehus
申办方类型
Other

研究点 (1)

Loading locations...

相似试验